| Literature DB >> 34621311 |
Jenniffer Puerta Suárez1, Walter D Cardona Maya1.
Abstract
BACKGROUND: In health, microorganisms have been associated with the disease, although the current knowledge shows that the microbiota present in various anatomical sites is associated with multiple benefits.Entities:
Year: 2021 PMID: 34621311 PMCID: PMC8492270 DOI: 10.1155/2021/1007366
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
NIH–CPSI classification of volunteers.
| Domain (score) | Symptoms classification, median (range) | ||
|---|---|---|---|
| Fertile group, control | Prostatitis-like symptoms | ||
| Pain (0–21) | 0 (0-1) | 11 (7–11) | 0.0079 |
| Urinary symptoms (0–10) | 1 (0–3) | 7 (6–10) | 0.0079 |
| Quality of life impact (0–12) | 0 (0–2) | 4 (2–5) | 0.0159 |
| Total score (0–43) | 1 (0–5) | 20 (20–26) | 0.0079 |
Seminal quality and oxidative stress in prostatitis-like symptoms men and fertile men.
| Fertile group, control, median (range) | Prostatitis-like symptoms, median (range) | ||
|---|---|---|---|
| Seminal volume (mL) | 4 (1.5–4.5) | 3 (1.5–7.5) | 0.7460 |
| Progressive motility (%) | 55.5 (41.5–81.0) | 57 (6.0–64.0) | 0.6667 |
| Nonprogressive motility (%) | 6.5 (2.0–16.0) | 6.0 (1.0–25.0) | 0.9524 |
| Immotile spermatozoa (%) | 39.0 (17.0–45.0) | 42.0 (29.0–90.0) | 0.8016 |
| Concentration/mL (106/mL) | 80.0 (40.5–270.0) | 205.0 (7.0–254.0) | 0.9444 |
| Total concentration (106/ejaculate) | 178.2 (115.5–1080.0) | 431.8 (22.4–1538.0) | 0.8016 |
| Viability (%) | 79.0 (77.0–90.0) | 70.0 (49.0–85.0) | 0.1667 |
| Sperm with normal morphology (%) | 4.8 (4.2–8.6) | 4.4 (2.8–6.8) | 0.8016 |
| Teratozoospermia index | 1.4 (1.1–1.5) | 1.2 (1.1–1.5) | 0.2222 |
| High mitochondrial membrane potential (%) | 63.2 (44.2–7.5) | 50.0 (12.3–55.5) | 0.0556 |
| Plasma membrane integrity (%) | 64.8 (48.1–84.4) | 35.8 (6.2–69.7) | 0.1508 |
| ROS production (%) | 64.3 (50.5–86.2) | 55.7 (17.7–61.9) | 0.0556 |
| DNA fragmentation index (%) | 10.6 (10.4–11.4) | 11.1 (10.5–14.3) | 0.3889 |
| Membrane lipid peroxidation (%) | 49.8 (9.1–80.5) | 67.0 (44.9–93.3) | 0.4127 |
| Antioxidant capacity of seminal plasma %) | 61.0 (45.3–81.4) | 62.0 (9.5–69.3) | 0.5317 |
| Serum nitric oxide (µM) | 3.7 (2.1–13.0) | 3.0 (1.7–4.1) | 0.5000 |
| Plasma nitric oxide (µM) | 1.5 (0.6–1.7) | 0.5 (0.2–1.9) | 0.3016 |
| PSA (ng/mL) | 0.0 (0.0–1.4) | 0.9 (0.0–120.0) | 0.3651 |
Mann–Whitney test. Data indicate median and range.
Concentrations of seminal cytokines in seminal and serum samples of the control group and prostatitis-like symptoms.
| Cytokine (pg/mL) | IL-12p70 | IL-10 | IL-1 | IL-6 | IL-8 | TNF | IL-2 | IL-4 | IL-10 | IL-17 | IFN- | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seminal samples | Fertile group | 0a (0–1.9) | 0 (0–0.8) | 0 (0–4.5) | 2.2 (0–32.7) | 1812.0 (997.9–3299) | 0 (0–7.1) | 0 (0–27.09) | 0 (0–6.3) | 1.5 (0.0–18.3) | 5.9 (5.3–10.2) | ND |
| Prostatitis-like symptoms group | 45.5 (0–252.8) | 1.0 (0–29.4) | 1.6 (0–31.6) | 6.0 (01–100.9) | 1230.0 (684.1–2533) | 47.75 (0–127.5) | 0.0 (0.0–116.3) | 0 (0–20.25) | 0.9 (0.0–21.3) | 8.1 (5.5–48.1) | 0 (0–22.1) | |
|
| ||||||||||||
| Serum samples | Fertile group | 0 (0–210.3) | 0 (0–199.1) | 0 (0–455.7) | 0 (0–304.2) | 24.4 (0–313.5) | 0 (0–50.8) | 1.0 (0.0–176.1) | 2.0 (0–13.5) | 0.0 (0.0–7.3) | 10.4 (9.1–24.8) | 0 (0–5.3) |
| Prostatitis-like symptoms group | ND | ND | ND | ND | 2.2 (0.0–11.5) | 0.0 (0.0–1.4) | 0.0 (0.0–21.9) | 4.5 (0–10.5) | 0 (0–3.1) | 17.1 (11.2–53.7) | 0 (0–27.3) | |
Data indicate median (range). ND, not detected. aSignificantly different from the control group: p < 0.05 (Mann–Whitney U test).
Figure 1Venn diagram of OTU overlapping in urine and semen samples. (a) Venn diagram obtained with semen and urine samples from chronic prostatitis symptoms and fertile men showing that both types of samples in both groups share 144 OTUs. (b) Semen and urine samples from volunteers with chronic prostatitis showing a lower amount of OTU than samples from fertile men in the control group.
Figure 2Different OTUs between prostatitis-like symptoms men and fertile men. Semen and urine samples from chronic prostatitis symptoms and fertile men differ statistically in 14 OTU. Most of them are not detectable by traditional culture techniques, which show the importance of sequencing in the study of prostate disease.